Medicare Enrolled
Dr. Mamta Vijayvargiya, MD
Hematology & Oncology · Orange City, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Vijayvargiya from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vijayvargiya?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Vijayvargiya
Dr. Mamta Vijayvargiya is a hematology & oncology specialist in Orange City, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Vijayvargiya performed 1,086 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Vijayvargiya received a total of $18,355 from 64 pharmaceutical and/or device companies across 531 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vijayvargiya is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 40% volume in FL
$18,355 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 83720 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗1,086
Medicare services
Top 40% in FL for hematology & oncology
Not available
Unique patients (not deduplicated)
$62
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
227 | $89 | $200 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
214 | $8 | $18 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
209 | $8 | $30 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
102 | $10 | $18 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
87 | $46 | $235 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
55 | $13 | $41 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
39 | $66 | $150 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
34 | $94 | $200 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
31 | $117 | $485 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 24 | $20 | $63 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
23 | $137 | $583 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
15 | $1,098 | $5,000 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 15 | $401 | $900 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
11 | $176 | $650 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
8.0% high complexity
2.4% medium
89.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$18,355
Total received (2018-2024)
Avg $2,622/year across 7 years
Top 27% in FL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
64
Companies
531
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,531
2023
$2,108
2022
$3,142
2021
$1,794
2020
$742
2019
$1,802
2018
$2,234
Payments by company (2024)
Karyopharm Therapeutics Inc.
$2,755
AstraZeneca Pharmaceuticals LP
$2,079
BeiGene USA, Inc.
$730
PFIZER INC.
$152
Novartis Pharmaceuticals Corporation
$135
Gilead Sciences, Inc.
$74
Celgene Corporation
$71
GlaxoSmithKline, LLC.
$62
Incyte Corporation
$58
GENZYME CORPORATION
$54
Janssen Biotech, Inc.
$44
Exelixis Inc.
$42
Bayer Healthcare Pharmaceuticals Inc.
$40
ABBVIE INC.
$34
TAIHO ONCOLOGY, INC.
$27
Takeda Pharmaceuticals U.S.A., Inc.
$26
Stemline Therapeutics Inc.
$24
Merck Sharp & Dohme LLC
$23
Daiichi Sankyo Inc.
$23
Genentech USA, Inc.
$23
JAZZ PHARMACEUTICALS INC.
$20
Mirati Therapeutics, Inc.
$18
EMD Serono, Inc.
$14
Top 3 companies account for 85.2% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$3,192
Karyopharm Therapeutics Inc.
$2,812
Novartis Pharmaceuticals Corporation
$2,266
Daiichi Sankyo Inc.
$1,412
PFIZER INC.
$906
BeiGene USA, Inc.
$766
Astellas Pharma US Inc
$695
Janssen Biotech, Inc.
$564
Celgene Corporation
$491
E.R. Squibb & Sons, L.L.C.
$468
Seagen Inc.
$418
Lilly USA, LLC
$397
GENZYME CORPORATION
$345
GlaxoSmithKline, LLC.
$313
Incyte Corporation
$257
COMSORT, Inc
$250
Seattle Genetics, Inc.
$238
Genentech USA, Inc.
$185
Athenex Pharmaceutical Division, LLC
$175
Exelixis Inc.
$158
Gilead Sciences, Inc.
$124
Takeda Pharmaceuticals U.S.A., Inc.
$123
Merck Sharp & Dohme LLC
$119
Kite Pharma, Inc.
$119
Bayer HealthCare Pharmaceuticals Inc.
$106
Amgen Inc.
$104
United Therapeutics Corporation
$100
ARRAY BIOPHARMA INC
$99
Boehringer Ingelheim Pharmaceuticals, Inc.
$94
JAZZ PHARMACEUTICALS INC.
$72
Mirati Therapeutics, Inc.
$61
Merck Sharp & Dohme Corporation
$59
Regeneron Healthcare Solutions, Inc.
$55
Bayer Healthcare Pharmaceuticals Inc.
$54
Alexion Pharmaceuticals, Inc.
$51
Epizyme, Inc.,
$51
Alnylam Pharmaceuticals Inc.
$49
Global Blood Therapeutics, Inc.
$43
TAIHO ONCOLOGY, INC.
$41
CTI BioPharma Corp.
$40
ABBVIE INC.
$34
Pharmacyclics LLC, An AbbVie Company
$33
Kyowa Kirin, Inc.
$30
EMD Serono, Inc.
$29
Deciphera Pharmaceuticals Inc.
$25
Stemline Therapeutics Inc.
$24
TerSera Therapeutics LLC
$23
MACROGENICS, INC.
$21
EISAI INC.
$21
Partner Therapeutics, Inc.
$20
SOBI, INC
$20
Pharmacosmos Therapeutics Inc.
$20
ADC Therapeutics America, Inc.
$19
Taiho Oncology, Inc.
$18
PUMA BIOTECHNOLOGY, INC.
$17
ACCORD HEALTHCARE, INC.
$17
TOLMAR Pharmaceuticals, Inc.
$16
MorphoSys, US Inc.
$15
AbbVie Inc.
$15
Verity Pharmaceuticals Inc.
$14
EUSA Pharma (US) LLC
$13
Puma Biotechnology, Inc.
$13
Rigel Pharmaceuticals, Inc.
$12
INSYS Therapeutics Inc
$11
Top 3 companies account for 45.1% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · Aliqopa · BAVENCIO · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · CABOMETYX · CALQUENCE · CAMCEVI · COSELA · CYRAMZA · Cabometyx · DARZALEX · Doptelet · ELIGARD · ELITEK · EMPLICITI · ENHERTU · ENJAYMO · ERLEADA · Enhertu · Erleada · FASLODEX · Fabhalta · GAZYVA · GILOTRIF · GIVLAARI · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · Inrebic · JADENU · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Leukine · Lonsurf · MARGENZA · MEKINIST · MONJUVI · Monoferric · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · OXBRYTA · Orserdu · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · Padcev · Perjeta · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · Revlimid · SANCUSO · SANDOSTATIN · SANDOSTATIN LAR · SCEMBLIX · SHINGRIX · SOLIRIS · SPRYCEL · SUTENT · SYNDROS · Stivarga · Sylvant · TAGRISSO · TASIGNA · TAZVERIK · TIVDAK · TUKYSA · Tavalisse · Trelstar · Truqap · ULTOMIRIS · UNITUXIN · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · Vonjo · XALKORI · XOSPATA · XPOVIO · XTANDI · Xtandi · Yescarta · ZEPZELCA · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
22
County median income
$66,581
Nearest hospital to ZIP centroid (approximate)
ADVENTHEALTH FISH MEMORIAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Vijayvargiya is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Vijayvargiya experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Vijayvargiya performed 227 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Vijayvargiya receive payments from pharmaceutical companies?
Yes. Dr. Vijayvargiya received a total of $18,355 from 64 companies across 531 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vijayvargiya's costs compare to other hematology & oncology specialists in Orange City?
Dr. Vijayvargiya's average Medicare payment per service is $62. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vijayvargiya) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Orange City
Browse hematology & oncology specialists in Orange City ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Karyopharm Therapeutics Inc. Payments to Doctors
See all physicians who received payments from Karyopharm Therapeutics Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology